In-Person Registration

Register to attend the "Amyloidosis Forum: Development of Imaging Endpoints" in-person on November 18, 2022.

Please complete the form below to register.

IMPORTANT: This is the registration form to attend in-person at the FDA White Oak Campus in Silver Spring, MD on the day of the event.


8:45 am
Welcome and Introductions
Isabelle Lousada & Rosalyn Adigun
8:55 am
Overview: The Central Role of Imaging-Based Biomarkers
Sharmila Dorbala
9:05 am
Animal Models for AL & ATTR Amyloidosis and the Need for Imaging
Christophe Sirac & Kevin Alexander
9:15 am
Biomarkers in Drug Development
Preston Dunnmon
9:25 am
Echocardiography: AL and ATTR Amyloidosis
Rodney Falk, Ashutosh Wechalekar, Grace Lin, Sarah Cuddy, & Cristina Quarta
9:55 am
Cardiac MRI: AL and ATTR Amyloidosis
Marianna Fontana, Frederick L. Ruberg, Justin L. Grodin, Michael Jerosch-Herold, & Michela Brambatti
10:25 am
10:35 am
Molecular Imaging of Amyloidosis-SPECT: ATTR Amyloidosis
Sharmila Dorbala, Mathew S. Maurer, Brett W. Sperry, Omar Abou Ezzeddine, Prem Soman, & John Vest
11:05 am
Molecular Imaging of Amyloidosis-PET: AL & ATTR Amyloidosis
Sharmila Dorbala, Michele Emdin, Jens Sörenson, Jonathan S. Wall, Spencer Guthrie, & Andrew Stephens
11:35 am
Connecting Changes in Amyloid Through Imaging with Changes in Cardiac Events, Functional Measures, & Health-Related Quality of Life
Ashutosh Wechalekar & Brett W. Sperry, moderated by Sarah Cuddy
11:55 am
Moderated Discussion: Standardization of Imaging in AL/ATTR Research

12:25 pm
1:05 pm
Laying the Groundwork for Qualifying Images as Potential Clinical Outcome Surrogates: How to Get There from Here
Preston Dunnmon
1:10 pm
Patient Perspectives: The Value of Imaging
Isabelle Lousada
1:20 pm
Case Study from Another Rare Disease: Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Ahmad Masri
1:30 pm
Images as Predictive Biomarkers (Trial Endpoint Surrogates): Current Thinking by the Health Authorities
Norman Stockbridge, Rosalyn Adigun, Joseph Rajendran, August Hofling, Nicole Gormley, Cynthia Welsh, Krishna Prasad, Clemens Mittmann, & Jean-Michel Race
2:05 pm
NIH HeartShare Study and BioData Catalyst
Vandana Sachdev
2:20 pm
2:30 pm
Moderated Discussion: Potential Pathway(s) for Imaging Biomarker Development in AL and ATTR Amyloidosis
3:30 pm
Closing Remarks
Isabelle Lousada & Rosalyn Adigun
3:40 pm